Not applicableUnknownNCT05760391What this trial is testingIO Plus Radiotherapy in Patients With Advanced ESCC.Who this might be right forMetastatic Esophageal Squamous Cell Carcinoma Fudan University 100
Testing effectiveness (Phase 2)Looking for participantsNCT06601309What this trial is testingBiomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCCWho this might be right forEsophageal Squamous Cell Carcinoma Fujian Medical University Union Hospital 90
Testing effectiveness (Phase 2)Study completedNCT01178944What this trial is testingPralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction CancerWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionEsophageal Undifferentiated CarcinomaGastric Adenocarcinoma+14 more Roswell Park Cancer Institute 35
Testing effectiveness (Phase 2)UnknownNCT05896787What this trial is testingCandonilimab (AK104) Plus Preoperative Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC)Who this might be right forEsophageal Squamous Cell Carcinoma The First Affiliated Hospital of Zhengzhou University 45
Early research (Phase 1)Study completedNCT04641871What this trial is testingSym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor MalignanciesWho this might be right forMetastatic CancerSolid Tumor Symphogen A/S 78
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06426797What this trial is testingNeoadjuvant Cadonilimab Combined With Anlotinib in Locally Advanced Resectable Esophageal Squamous Cell CarcinomaWho this might be right forLocally Advanced Esophageal Squamous Cell Carcinoma Peking University People's Hospital 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07688291What this trial is testingA Phase II Study of PD-1/IL-2α-bias Bispecific Antibody Fusion Protein Monotherapy in Advanced Esophageal Squamous Cell Carcinoma After Failure of Prior ICI Plus Platinum-Based ChemotherapyWho this might be right forEsophageal Squamous Carcinoma Cell Beijing GoBroad Hospital 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06852456What this trial is testingQL1706 in Combination With Neoadjuvant Chemotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced, Resectable Esophageal Squamous Cell CarcinomaWho this might be right forResectable Locally Advanced Esophageal Squamous Cell Carcinoma Qilu Pharmaceutical Co., Ltd. 30
Not applicableUnknownNCT05050760What this trial is testingDCF Combined With Camrelizumab in the Treatment of Esophageal CancerWho this might be right forESCC Xijing Hospital 55
Large-scale testing (Phase 3)Active Not RecruitingNCT04550260What this trial is testingStudy of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCCWho this might be right forEsophageal Squamous Cell Carcinoma AstraZeneca 640
Testing effectiveness (Phase 2)Study completedNCT00238407What this trial is testingDocetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By SurgeryWho this might be right forEsophageal Cancer Swiss Cancer Institute 21
Testing effectiveness (Phase 2)Looking for participantsNCT07559045What this trial is testingInduction Chemo-Immunotherapy + Radiotherapy vs Concurrent Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma (ESCC) Second Affiliated Hospital of Zunyi Medical University 92
Not applicableStudy completedNCT04670445What this trial is testingImproving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerWho this might be right forStage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more Massachusetts General Hospital 199
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07823270What this trial is testingNeoadjuvant Sacituzumab Tirumotecan Plus Toripalimab in Locally Advanced Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma Hebei Medical University Fourth Hospital 33
Not applicableNot Yet RecruitingNCT07769866What this trial is testingRetlirafusp Alfa Combined With Chemoradiotherapy in Unresectable ESCCWho this might be right forEsophageal Squamous Cell Cancer RenJi Hospital 68
Not applicableNot Yet RecruitingNCT06756841What this trial is testingSafety and Efficacy Study of Pulsed Electric Field (PEF) Therapy in Patients With Advanced or Unresectable Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Cancer Energenx Medical LTD. 10
Testing effectiveness (Phase 2)Study completedNCT06010303What this trial is testingEvaluate LBL-007 in Combination With Tislelizumab Plus Chemotherapy in Participants With Unresectable Locally Advanced or Metastatic Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal CancerEsophageal Squamous Cell CarcinomaEsophageal Squamous Cell Carcinoma by AJCC V8 Stage BeiGene 118
Testing effectiveness (Phase 2)UnknownNCT04602013What this trial is testingSintilimab Injection Combined With Concurrent CCRT in Locally Advanced Esophageal Squamous Cell CarcinomaWho this might be right forLocally Advanced Esophageal Squamous Cell Carcinoma Sichuan Cancer Hospital and Research Institute 53
Testing effectiveness (Phase 2)Looking for participantsNCT07188103What this trial is testingIvonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma Anhui Provincial Hospital 37
Large-scale testing (Phase 3)Looking for participantsNCT04807673What this trial is testingPembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)Who this might be right forEsophageal Squamous Cell Carcinoma Tianjin Medical University Cancer Institute and Hospital 342